In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study
Youn H. Kim(Stanford University), Cameron Harrison, Joshua Brody(New York University), Robert Tibshirani(Stanford University), Daniel Navi, Weiyun Z. Ai(City College of San Francisco), Ranjana H. Advani(Stanford Medicine), Leon Xing, Dita Gratzinger(Stanford University), Anjali V. Morales, Farah Abdulla(Caris Life Sciences (United States)), Richard T. Hoppe(Stanford Medicine), Yasodha Natkunam(Palo Alto University), Debra K. Czerwinski(Stanford University)
Cited by 1
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
|Immunity|2016|1.2k
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
|Journal of Clinical Oncology|2012|1.1k